TGFB1 and diabetic kidney disease: 1991) and in the development of several fibrotic processes. It promotes ECM deposition by inducing fibroblasts to differentiate and synthesise fibrotic components (Leask & Abraham, 2004). The expression of TGFB1 was found to be elevated in human experimental diabetic kidney diseases (Yamamoto et al. 1993).